Opaleye Management Inc.
Filing Date
Global Rank
#2,102
/ 8,586
▲ 43
Top Industry
Biotechnology
57.5%
3Y Alpha vs SPY
+19.0%
Period ended 3 months ago
Filed May 15, 2026 · 32d
25 quarters · since Mar 2020
Clone Performance
Jun 2023–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+175.8%
SPY
+78.1%
Annualised alpha
+19.0%
Max drawdown
−42.1%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
53 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
13.4%
−12.1 pts
Top 5
45.6%
−6.3 pts
Top 10
61.6%
−4.6 pts
HHI
593
Diversified−353
Portfolio Trend
25 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $743,833,828 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
18 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| CATX | Perspective Therapeutics, Inc. | +3,490,500 | 4,675,000 | $19,494,750 | |
| MGTX | MeiraGTx Holdings plc | +1,732,415 | 2,123,259 | $18,387,422 | |
| URGN | UroGen Pharma Ltd. | +1,161,577 | 1,430,000 | $25,711,400 | |
| QTTB | Q32 Bio Inc. | +1,042,865 | 1,256,228 | $8,064,983 | |
| ACOG | Alpha Cognition Inc. | +491,166 | 2,561,950 | $14,065,105 | |
| CABA | Cabaletta Bio, Inc. | +480,000 | 1,380,000 | $3,712,200 | |
| IRON | Disc Medicine, Inc. | +221,000 | 421,000 | $26,918,740 | |
| AVIR | Atea Pharmaceuticals, Inc. | +142,785 | 322,600 | $1,735,588 | |
| CBIO | Crescent Biopharma, Inc. | +134,315 | 1,312,615 | $24,112,737 | |
| LQDA | Liquidia Corp | +110,000 | 2,545,000 | $96,048,300 | |
| ENTA | Enanta Pharmaceuticals Inc | +50,000 | 125,000 | $1,578,750 | |
| SLGL | Sol-Gel Technologies Ltd. | +46,261 | 500,000 | $39,610,000 | |
| ALMS | Alumis Inc. | +15,000 | 550,000 | $12,116,500 | |
| RZLT | Rezolute, Inc. | +12,844 | 6,300,000 | $19,215,000 | |
| ZNTL | Zentalis Pharmaceuticals, Inc. | +11,750 | 1,412,656 | $3,305,615 | |
| XOMA | XOMA Royalty Corp | +7,410 | 300,000 | $9,411,000 | |
| STOK | Stoke Therapeutics, Inc. | +5,000 | 700,000 | $22,792,000 | |
| APGE | Apogee Therapeutics, Inc. | +1,743 | 390,000 | $32,826,300 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
12 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| PLX | Protalix BioTherapeutics, Inc. | −2,138,176 | 340,000 | $737,800 | |
| HROW | Harrow, Inc. | −1,072,770 | 2,832,230 | $99,864,429 | |
| OCUL | Ocular Therapeutix, Inc | −995,000 | 600,000 | $5,082,000 | |
| CGON | CG Oncology, Inc. | −315,200 | 94,800 | $6,416,064 | |
| ANNX | Annexon, Inc. | −268,239 | 2,331,761 | $12,917,955 | |
| RYTM | Rhythm Pharmaceuticals, Inc. | −207,000 | 123,000 | $10,697,310 | |
| TECX | Tectonic Therapeutic, Inc. | −91,747 | 123,000 | $3,801,930 | |
| FBIO | Fortress Biotech, Inc. | −48,000 | 1,042,000 | $2,907,180 | |
| VYGR | Voyager Therapeutics, Inc. | −46,904 | 1,150,000 | $4,439,000 | |
| DERM | Journey Medical Corp | −15,000 | 960,000 | $4,502,400 | |
| PTGX | Protagonist Therapeutics, Inc | −5,000 | 100,000 | $10,540,000 | |
| CDXS | Codexis, Inc. | −4,738 | 6,785,000 | $11,059,550 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
9 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| ASRT | Assertio Holdings, Inc. | 265,707 | $5,064,375 | |
| EDIT | Editas Medicine, Inc. | 1,926,997 | $4,759,682 | |
| BDSX | Biodesix Inc | 238,047 | $3,451,681 | |
| NTLA | Intellia Therapeutics, Inc. | 245,000 | $3,140,900 | |
| LYEL | Lyell Immunopharma, Inc. | 79,097 | $1,586,685 | |
| NXTC | NextCure, Inc. | 141,181 | $1,507,813 | |
| FDMT | 4D Molecular Therapeutics, Inc. | 112,291 | $1,045,429 | |
| BBOT | BridgeBio Oncology Therapeutics, Inc. | 53,282 | $476,873 | |
| LBRX | Lb Pharmaceuticals Inc | 14,506 | $357,717 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
6 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| ALKS | Alkermes plc. | 490,000 | $13,710,200 | |
| GOSS | Gossamer Bio, Inc. | 2,720,000 | $8,432,000 | |
| KPTI | Karyopharm Therapeutics Inc. | 930,000 | $6,844,800 | |
| ZYME | Zymeworks Inc. | 108,929 | $2,868,100 | |
| BBIO | BridgeBio Pharma, Inc. | 18,319 | $1,401,220 | |
| SLN | Silence Therapeutics plc | 78,926 | $479,870 | |
| No positions match the current search. | ||||
53 positions ·
$743,833,828 total
· as of Mar 31, 2026
Showing 1–50
of 53 positions by value
· page 1 of 2
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| HROW |
Harrow, Inc.
Healthcare
|
Reduced | 2,832,230 | $99,864,429 | 13.43% | |
| LQDA |
Liquidia Corp
Healthcare
|
Added | 2,545,000 | $96,048,300 | 12.91% | |
| ETON |
Eton Pharmaceuticals, Inc.
Healthcare
|
Held | 2,860,000 | $70,584,800 | 9.49% | |
| SLGL |
Sol-Gel Technologies Ltd.
Healthcare
|
Added | 500,000 | $39,610,000 | 5.33% | |
| APGE |
Apogee Therapeutics, Inc.
Healthcare
|
Added | 390,000 | $32,826,300 | 4.41% | |
| IRON |
Disc Medicine, Inc.
Healthcare
|
Added | 421,000 | $26,918,740 | 3.62% | |
| URGN |
UroGen Pharma Ltd.
Healthcare
|
Added | 1,430,000 | $25,711,400 | 3.46% | |
| CBIO |
Crescent Biopharma, Inc.
Healthcare
|
Added | 1,312,615 | $24,112,737 | 3.24% | |
| STOK |
Stoke Therapeutics, Inc.
Healthcare
|
Added | 700,000 | $22,792,000 | 3.06% | |
| CATX |
Perspective Therapeutics, Inc.
Healthcare
|
Added | 4,675,000 | $19,494,750 | 2.62% | |
| RZLT |
Rezolute, Inc.
Healthcare
|
Added | 6,300,000 | $19,215,000 | 2.58% | |
| MGTX |
MeiraGTx Holdings plc
Healthcare
|
Added | 2,123,259 | $18,387,422 | 2.47% | |
| TGTX |
Tg Therapeutics, Inc.
Healthcare
|
Held | 535,000 | $17,772,700 | 2.39% | |
| SNWV |
SANUWAVE Health, Inc.
Healthcare
|
Held | 981,267 | $16,966,106 | 2.28% | |
| EWTX |
Edgewise Therapeutics, Inc.
Healthcare
|
Held | 500,000 | $15,750,000 | 2.12% | |
| ACOG |
Alpha Cognition Inc.
Healthcare
|
Reduced | 2,561,950 | $14,065,105 | 1.89% | |
| ANNX |
Annexon, Inc.
Healthcare
|
Reduced | 2,331,761 | $12,917,955 | 1.74% | |
| ALMS |
Alumis Inc.
Healthcare
|
Added | 550,000 | $12,116,500 | 1.63% | |
| CDXS |
Codexis, Inc.
Healthcare
|
Reduced | 6,785,000 | $11,059,550 | 1.49% | |
| RYTM |
Rhythm Pharmaceuticals, Inc.
Healthcare
|
Reduced | 123,000 | $10,697,310 | 1.44% | |
| PTGX |
Protagonist Therapeutics, Inc
Healthcare
|
Reduced | 100,000 | $10,540,000 | 1.42% | |
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
Held | 100,000 | $9,725,000 | 1.31% | |
| XOMA |
XOMA Royalty Corp
Healthcare
|
Added | 300,000 | $9,411,000 | 1.27% | |
| QTTB |
Q32 Bio Inc.
Healthcare
|
Added | 1,256,228 | $8,064,983 | 1.08% | |
| MBX |
MBX Biosciences, Inc.
Healthcare
|
Held | 260,000 | $7,761,000 | 1.04% | |
| RLMD |
Relmada Therapeutics, Inc.
Healthcare
|
Held | 935,000 | $6,507,600 | 0.87% | |
| CGON |
CG Oncology, Inc.
Healthcare
|
Reduced | 94,800 | $6,416,064 | 0.86% | |
| JBIO |
Jade Biosciences, Inc.
Healthcare
|
Held | 427,608 | $6,007,892 | 0.81% | |
| IRD |
Opus Genetics, Inc.
Healthcare
|
Held | 1,120,000 | $5,096,000 | 0.69% | |
| OCUL |
Ocular Therapeutix, Inc
Healthcare
|
Reduced | 600,000 | $5,082,000 | 0.68% | |
| ASRT |
Assertio Holdings, Inc.
Healthcare
|
NEW | 265,707 | $5,064,375 | 0.68% | |
| EDIT |
Editas Medicine, Inc.
Healthcare
|
NEW | 1,926,997 | $4,759,682 | 0.64% | |
| STRO |
Sutro Biopharma, Inc.
Healthcare
|
Held | 190,671 | $4,749,614 | 0.64% | |
| DERM |
Journey Medical Corp
Healthcare
|
Reduced | 960,000 | $4,502,400 | 0.61% | |
| VYGR |
Voyager Therapeutics, Inc.
Healthcare
|
Reduced | 1,150,000 | $4,439,000 | 0.60% | |
| TRVI |
Trevi Therapeutics, Inc.
Healthcare
|
Held | 345,100 | $4,117,043 | 0.55% | |
| TECX |
Tectonic Therapeutic, Inc.
Healthcare
|
Reduced | 123,000 | $3,801,930 | 0.51% | |
| CABA |
Cabaletta Bio, Inc.
Healthcare
|
Added | 1,380,000 | $3,712,200 | 0.50% | |
| BDSX |
Biodesix Inc
Healthcare
|
NEW | 238,047 | $3,451,681 | 0.46% | |
| RCKT |
Rocket Pharmaceuticals, Inc.
Healthcare
|
Held | 955,000 | $3,418,900 | 0.46% | |
| ZNTL |
Zentalis Pharmaceuticals, Inc.
Healthcare
|
Added | 1,412,656 | $3,305,615 | 0.44% | |
| NTLA |
Intellia Therapeutics, Inc.
Healthcare
|
NEW | 245,000 | $3,140,900 | 0.42% | |
| FBIO |
Fortress Biotech, Inc.
Healthcare
|
Reduced | 1,042,000 | $2,907,180 | 0.39% | |
| RIGL |
Rigel Pharmaceuticals Inc
Healthcare
|
Held | 70,000 | $1,892,800 | 0.25% | |
| AVIR |
Atea Pharmaceuticals, Inc.
Healthcare
|
Added | 322,600 | $1,735,588 | 0.23% | |
| LYEL |
Lyell Immunopharma, Inc.
Healthcare
|
NEW | 79,097 | $1,586,685 | 0.21% | |
| ENTA |
Enanta Pharmaceuticals Inc
Healthcare
|
Added | 125,000 | $1,578,750 | 0.21% | |
| NXTC |
NextCure, Inc.
Healthcare
|
NEW | 141,181 | $1,507,813 | 0.20% | |
| FDMT |
4D Molecular Therapeutics, Inc.
Healthcare
|
NEW | 112,291 | $1,045,429 | 0.14% | |
| PLX |
Protalix BioTherapeutics, Inc.
Healthcare
|
Reduced | 340,000 | $737,800 | 0.10% |